Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Accounts Payables data on file, last reported at $10.5 billion in Q1 2026.

• Quarterly Accounts Payables rose 9.59% year-over-year to $10.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 9.59% YoY) and the FY2025 annual result came in at $12.0 billion, up 16.29% from the prior year.
• Accounts Payables eased to $10.5 billion in Q1 2026 per JNJ's latest filing, from $12.0 billion in the prior quarter.
• The five-year high for Accounts Payables was $12.0 billion in Q4 2025, with the low at $8.2 billion in Q1 2024.
• Average Accounts Payables over 5 years is $9.8 billion, with a median of $9.7 billion recorded in 2022.
• Year-over-year, Accounts Payables dropped 17.71% in 2023 and advanced 16.77% in 2025.
• Johnson & Johnson's Accounts Payables stood at $10.2 billion in 2022, then dropped by 5.13% to $9.6 billion in 2023, then advanced by 7.05% to $10.3 billion in 2024, then grew by 16.29% to $12.0 billion in 2025, then declined by 12.77% to $10.5 billion in 2026.
• Business Quant data shows JNJ's Accounts Payables at $10.5 billion in Q1 2026, $12.0 billion in Q4 2025, and $9.6 billion in Q3 2025.